Related Experiment Video
Updated: Jun 14, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells
Ella L Kim1, Robin Wüstenberg, Anne Rübsam
1The Translational Neurooncology Research Group, Department of Neurosurgery, Georg-August University Göttingen, Robert-Koch-Strasse 40, 37075 Göttingen, Germany. ella.kim@med.uni-goettingen.de
Abstract:
Glioblastoma is the most common malignant brain tumor in adults. The currently available treatments offer only a palliative survival advantage and the need for effective treatments remains an urgent priority. Activation of the p53 growth suppression/apoptotic pathway is one of the promising strategies in targeting glioma cells. We show that the quinoline derivative chloroquine activates the p53 pathway and suppresses growth of glioma cells in vitro and in vivo in an orthotopic (U87MG) human glioblastoma mouse model. Induction of apoptosis is one of the mechanisms underlying the effects of chloroquine on suppressing glioma cell growth and viability. siRNA-mediated downregulation of p53 in wild-type but not mutant p53 glioblastoma cells substantially impaired chloroquine-induced apoptosis. In addition to its p53-activating effects, chloroquine may also inhibit glioma cell growth via p53-independent mechanisms. Our results clarify the mechanistic basis underlying the antineoplastic effect of chloroquine and reveal its therapeutic potential as an adjunct to glioma chemotherapy.
Insights
Chloroquine activates the p53 pathway, suppressing growth and inducing apoptosis in glioblastoma cells. This quinoline derivative shows therapeutic potential as an adjunct to chemotherapy for brain tumors.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Glioblastoma is a highly aggressive brain tumor with limited treatment options.
- Targeting the p53 pathway is a promising strategy for glioblastoma therapy.
- Novel therapeutic agents are urgently needed to improve patient outcomes.
Purpose of the Study:
- To investigate the anti-cancer effects of chloroquine on glioblastoma cells.
- To elucidate the role of the p53 pathway in chloroquine's mechanism of action.
- To evaluate chloroquine's therapeutic potential in a glioblastoma mouse model.
Main Methods:
- In vitro cell culture experiments using glioblastoma cell lines (U87MG).
- In vivo studies utilizing an orthotopic human glioblastoma mouse model.
- siRNA-mediated p53 gene silencing to assess pathway involvement.
- Assessment of cell viability, apoptosis, and growth suppression.
Main Results:
- Chloroquine demonstrated significant suppression of glioblastoma cell growth both in vitro and in vivo.
- Chloroquine treatment led to the induction of apoptosis in glioma cells.
- siRNA-mediated p53 knockdown partially inhibited chloroquine-induced apoptosis, highlighting p53's role.
- Evidence suggests both p53-dependent and independent mechanisms contribute to chloroquine's anti-glioma effects.
Conclusions:
- Chloroquine exhibits potent anti-glioma activity by activating the p53 pathway and inducing apoptosis.
- Chloroquine's efficacy involves both p53-dependent and independent mechanisms.
- Chloroquine represents a promising therapeutic agent for glioblastoma, potentially enhancing existing chemotherapy regimens.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...